John Boyer Inc’s Bristol-Myers Squibb BMY Stock Holding History

John Boyer Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21K	Buy	+337	New	+$21.3K	0.02%	134

Other funds holding BMY

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

John Boyer Inc's BMY Position: Q3 2026 in Review

John Boyer Inc opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 337 shares worth $21K. The stake represents 0.02% of the portfolio and ranks #134 among its holdings.

2,087 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

John Boyer Inc held 337 shares of Bristol-Myers Squibb worth $21K as of Q3 2026.
Bristol-Myers Squibb was a new John Boyer Inc position in Q3 2026.
Bristol-Myers Squibb made up 0.02% of John Boyer Inc's portfolio in Q3 2026, its #134 holding.
2,087 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on John Boyer Inc's 13F filing for Q3 2026, filed 27 Oct 2026.